化脓性汗腺炎的创新疗法。
Innovations in Hidradenitis Suppurativa.
机构信息
David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.
Department of Dermatology, University of Southern California, 1441 Eastlake Avenue, Los Angeles, CA 90033, USA.
出版信息
Dermatol Clin. 2025 Jan;43(1):35-53. doi: 10.1016/j.det.2024.08.003. Epub 2024 Oct 22.
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by painful, recurrent abscesses, inflammatory nodules, and draining tunnels. Biologic and small molecule therapeutics are effective for treatment of moderate-to-severe HS. The field of HS is rapidly growing with numerous ongoing clinical trials exploring novel agents. This review highlights the latest discoveries in the field of HS, with a particular focus on novel therapeutic agents and procedural management.
化脓性汗腺炎（HS）是一种慢性炎症性皮肤病，其特征为疼痛、反复发作的脓肿、炎症性结节和引流窦道。生物制剂和小分子治疗药物对中重度 HS 的治疗有效。HS 领域正在迅速发展，许多正在进行的临床试验正在探索新的药物。本文重点介绍 HS 领域的最新发现，特别是新型治疗药物和治疗方法。
Zotero 插件